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Introduction
Sox10 belongs to the group of HMG (high mobility group)   
domain–containing transcription factors (Wegner, 1999; Bowles 
et al., 2000). During vertebrate development, it is highly ex-
pressed in the emerging neural crest and later in the developing 
peripheral nervous system (PNS) and central nervous system, 
where its occurrence is restricted to glial cells (Kuhlbrodt et al., 
1998). Accordingly, loss of Sox10 in the mouse leads to de-
creased survival of early neural crest cells and additionally to 
defects in several neural crest–derived lineages (Herbarth et al., 
1998; Southard-Smith et al., 1998; Kapur, 1999; Britsch et al., 
2001; Paratore et al., 2001; Kim et al., 2003). These also be-
come evident in patients with heterozygous SOX10 mutations   
as Waardenburg syndrome, Hirschsprung disease, peripheral 
neuropathies, or combinations thereof (Pingault et al., 1998;   
Inoue et al., 2004; Bondurand et al., 2007).
In the developing PNS of Sox10-deficient mice, both neu-
rons and glia are affected, but to different extents (Britsch et al., 
2001). Whereas at least some neurons are formed, glia are not 
detected either in vivo or in vitro (Britsch et al., 2001; Paratore 
et al., 2001). It follows that Sox10 is absolutely required for 
glial development in the PNS. This includes the development   
of satellite glia in peripheral ganglia, enteric glia in the gastro-
intestinal tract, and Schwann cells along nerves.
Schwann  cell  development  has  been  particularly  well 
studied in the past, and markers are available for all develop-
mental stages (Jessen and Mirsky, 2005). Bfabp (brain fatty 
acid–binding protein), for instance, is normally induced as 
M
utations in the transcription factor SOX10 cause 
neurocristopathies, including Waardenburg-
Hirschsprung syndrome and peripheral neurop-
athies in humans. This is partly attributed to a requirement 
for Sox10 in early neural crest for survival, maintenance   
of pluripotency, and specification to several cell lineages, 
including peripheral glia. As a consequence, peripheral 
glia are absent in Sox10-deficient mice. Intriguingly, 
Sox10 continues to be expressed in these cells after speci-
fication. To analyze glial functions after specification, 
we  specifically  deleted  Sox10  in  immature  Schwann 
cells by conditional mutagenesis. Mutant mice died from   
peripheral neuropathy before the seventh postnatal week. 
Nerve alterations included a thinned perineurial sheath, 
increased lipid and collagen deposition, and a dramati-
cally altered cellular composition. Nerve conduction was 
also grossly aberrant, and neither myelinating nor non-
myelinating Schwann cells formed. Instead, axons of dif-
ferent sizes remained unsorted in large bundles. Schwann 
cells failed to develop beyond the immature stage and 
were unable to maintain identity. Thus, our study identifies 
a novel cause for peripheral neuropathies in patients with 
SOX10 mutations.
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even after the specification event. Sox10 has indeed been found to 
activate peripheral myelin genes in tissue culture and to be bound 
to the responsible regulatory regions both in vitro and in vivo 
(Peirano et al., 2000; LeBlanc et al., 2007). However, later func-
tions of Sox10 cannot be verified and studied in the available 
mouse models of Sox10. Therefore, we generated an allele that 
allows cell type–specific and temporally controlled deletion of 
Sox10 and used this allele to prove an additional requirement for 
Sox10  during  Schwann  cell  development  at  the  immature 
Schwann cell stage.
Results
Generation of mice with a floxed  
Sox10 allele
The mouse Sox10 gene is encoded by five exons, with the ORF 
being split among exons 3–5 (Britsch et al., 2001). To generate 
a Sox10 allele that is sensitive to the presence of Cre recombinase 
and will undergo Cre-dependent gene inactivation, we replaced 
the protein-coding information on exons 3–5 by a continuous 
ORF in such a way that its start codon was placed exactly at the   
Schwann cell precursors are specified from neural crest cells 
and represents the earliest glial marker (Britsch et al., 2001). 
From the immature stage onwards, Schwann cells transiently 
express Sox2, an HMG domain transcription factor distantly   
related to Sox10 (Le et al., 2005). Sox2 expression again   
extinguishes as Schwann cells undergo differentiation. For 
differentiation to myelinating Schwann cells, the transcription 
factor Oct6, which is indicative of the promyelinating stage, has 
to be induced first, followed by Krox20 expression and full-blown 
myelin gene expression (Topilko et al., 1994; Bermingham et al., 
1996; Jaegle et al., 1996; Jessen and Mirsky, 2005).
From the fact that neither Bfabp nor ErbB3 as the earliest 
marker in the Schwann cell lineage are expressed in the develop-
ing PNS of Sox10-deficient mice, Sox10 appears already required 
for glial specification (Britsch et al., 2001). However, even after 
specification, Sox10 continues to be expressed in PNS glia. As a 
consequence, Sox10 is not only present in Schwann cell precur-
sors but also in immature and promyelinating Schwann cells and 
even persists in the myelinating and nonmyelinating Schwann 
cells of the adult PNS (Kuhlbrodt et al., 1998). This expression 
pattern argues for additional roles of Sox10 in peripheral glia 
Figure  1.  Generation  of  a  conditional  Sox10  allele  in 
mice. (A) Schematic representation, from top to bottom, 
of  the  targeting  construct,  the  wild-type  Sox10  allele 
(Sox10
+), the conditional Sox10 allele before (Sox10
flneo) 
and after (Sox10
fl) removal of the neo selection cassette 
by Flp recombinase, and the deleted allele (Sox10
) after 
Cre recombination. Sox10 exons (I–V) and the continu-
ous Sox10 ORF used in the conditional allele are shown 
as boxes, and 4.5- and 1.5-kb-long flanking regions are 
shown as bars. Regions of homology between wild-type 
locus and targeting vector are depicted as black bars, 
introns 3 and 4 are depicted as open bars, and surround-
ing genomic regions not contained in the targeting con-
struct  are  depicted  as  dashed  bars.  Plasmid  backbone 
sequences of the targeting construct are indicated by a 
thin line. Restriction sites for NcoI (N), BamHI (B), and ScaI 
(S) are shown as well as the localization of 5 and 3 
probes and the start codon of the Sox10 gene (ATG). neo, 
neomycin resistance cassette; FRT, recognition sites for Flp 
recombinase (depicted as ellipses); loxP, recognition sites 
for Cre recombinase (depicted as triangles); Tk, Herpes 
simplex virus thymidine kinase gene cassette. (B) South-
ern blot analysis of genomic DNA from Sox10
+/+ (wt) and 
Sox10
fl/fl (fl/fl) mice digested with NcoI for use of the 5 
probe and BamHI–ScaI for the 3 probe. The size of bands 
corresponding to the wild-type (6.6 kb for the 5 probe 
and  4.6  kb  for  the  3  probe)  and  the  targeted  alleles   
(4.8 kb for the 5 probe and 3.7 kb for the 3 probe) are 
indicated. (C) PCR genotyping of Sox10
+/+ (wt), Sox10
+/fl 
(+/fl), and Sox10
fl/fl (fl/fl) mice. Size of DNA fragments 
in the marker (M) is indicated in kilobases on the left.   
(D) Whole mount GFP autofluorescence of Sox10
fl/fl em-
bryos  at  10.5  dpc.  (E)  Immunohistochemistry  with  anti-
bodies directed against Sox10 on transverse sections from 
the thoracic region of Sox10
+/+ (wt) and Sox10
fl/fl (fl/fl) 
embryos at 12.5 dpc. (F) Comparison of expression levels 
for Sox10 in Sox10
+/+ (wt) and Sox10
fl/fl (fl/fl) embryos at 
12.5 dpc with primers recognizing a common sequence 
in  both  transcripts  using  quantitative  LightCycler  RT-PCR. 
Transcript levels in each sample were normalized to Rpl8. 
After normalization, transcript levels in the wild type were 
arbitrarily set to 1, and transcript levels in Sox10
fl/fl are ex-
pressed relative to wild-type levels ± SEM. Experiments were 
repeated twice with material from two independently ob-
tained embryos for each genotype and age. Bars: (D) 1 mm;   
(E) 100 µm.703 Sox10 function in Schwann cell development • Finzsch et al.
of Sox10-positive nuclei along the nerve had dropped to 29% 
in the mutant compared with 73% in the wild type (Fig. 2,   
H and J). At 18.5 dpc, only 4% of all nuclei along the mutant 
nerve were still Sox10 positive, whereas 70% continued to 
express Sox10 in the wild type (Fig. 2, I and J). We conclude 
position of the endogenous start codon in exon 3 (Fig. 1 A). 
Additionally, loxP sequences were introduced immediately 
preceding  and  following  the  continuous  Sox10  ORF. The   
5 loxP sequence was placed in the hind part of intron 2 in suffi-
cient distance to branch and splice acceptor site to avoid inter-
ference with the splicing of the altered allele. After successful 
homologous recombination of the targeting construct in embry-
onic stem (ES) cells, germline transmission, and removal of 
the neomycin selection cassette (Fig. 1, A and B), both hetero-
zygous and homozygous animals carrying the Sox10
fl allele 
were obtained in Mendelian ratios (Fig. 1 C and not depicted). 
The additional introduction of an IRES (internal ribosomal   
entry  site)-EGFP  cassette  furthermore  allowed  visualization   
of the unrecombined Sox10
fl allele by GFP autofluorescence 
(Fig. 1 D). Fluorescence was lost upon Cre-mediated recombina-
tion, probably because the IRES-EGFP cassette is no longer cor-
rectly spliced to exon 2 (unpublished data).
Similar  strategies  have  previously  been  used  to  replace 
Sox10 by other SoxE genes or mutant versions of Sox10. These 
genetic manipulations had not led to dramatic alterations of   
expression levels from the Sox10 locus (Kellerer et al., 2006;   
Schreiner et al., 2007; Cossais et al., 2010). Expression of the 
Sox10
fl allele was also comparable to the wild type, as evident 
from similar intensities of Sox10 immunoreactivity in age-matched 
embryos of both genotypes (Fig. 1 E) and comparable expression 
levels in quantitative RT-PCR experiments (Fig. 1 F and not de-
picted). Detailed side by side comparison furthermore showed   
a very similar, if not identical, temporal and spatial pattern of 
Schwann cell development in Sox10
+/+ and Sox10
fl/fl mice so that 
both genotypes could be used interchangeably as wild-type con-
trol throughout this study.
Schwann cell–specific Sox10 deletion
To achieve specific Sox10 deletion in Schwann cells after the 
specification event, we combined the Sox10
fl allele with a 
Dhh::Cre transgene (Jaegle et al., 2003). This Cre transgene 
selectively deleted in the Schwann cell lineage and started to 
be active around 12.5 d postcoitum (dpc) in the Schwann cell 
precursor stage (Fig. 2 A). The resulting Sox10
fl/fl Dhh::Cre 
mice are referred to as Sox10
eSC mice throughout the manu-
script. First, we determined the kinetics with which Sox10 
disappeared from Schwann cells. Whereas Cre-dependent re-
combination of a Rosa26
stopfloxYFP allele had occurred in 70% 
of cells in the proximal spinal nerve at 13.5 dpc and was more 
or less complete at 14.5 dpc (Fig. 2, B and C), Sox10 tran-
scripts were still detected in normal amounts at 13.5 dpc   
(Fig. 2 D). Residual amounts of Sox10 transcripts were still 
detectable at 14.5 dpc (Fig. 2, E and F), indicating that Cre-
dependent recombination may be less efficient for the Sox10
fl 
allele than for the Rosa26
stopfloxYFP allele (Fig. 2, E and F). Loss 
of Sox10 protein as the essential determinant for function took 
even longer. Sox10 was still expressed in 84% of all DAPI-
positive nuclei along the spinal nerve in Sox10
eSC mice at 
14.5 dpc. This is only slightly lower than the 90% observed in 
the wild type (Fig. 2, G and J). At this stage, most glia along 
the spinal nerve have already entered the immature Schwann 
cell stage (Jessen and Mirsky, 2005). By 16.5 dpc, the percentage 
Figure  2.  Kinetics  of  Sox10  deletion  in  spinal  nerves  of  Sox10
eSC  
embryos. (A–C) Cre activity in spinal nerves was monitored by YFP auto-
fluorescence (green) on transverse sections of Dhh::Cre, Rosa26
stopfloxYFP 
(Rosa26
DhhYFP) embryos at 12.5 (A), 13.5 (B), and 14.5 dpc (C). Anti-
Sox10 immunofluorescence (red) is shown for comparison. The border be-
tween peripheral nerve and dorsal root ganglion is indicated by a dotted 
line. (D–F) Loss of Sox10 transcripts in spinal nerves of Sox10
eSC embryos 
was determined by in situ hybridization on transverse sections at 13.5 (D), 
14.5 (E), and 16.5 dpc (F) using a Sox10-specific antisense riboprobe. 
(G–I) Disappearance of Sox10 protein in spinal nerves of Sox10
eSC em-
bryos was assessed by immunohistochemistry on transverse sections of 
Sox10
eSC embryos at 14.5 (G), 16.5 (H), and 18.5 dpc (I) using a Sox10-
specific antibody (red), followed by DAPI staining of nuclei (blue). (A–I) 
Proximal regions of spinal nerves are shown. (J) The percentage of Sox10-
positive nuclei in spinal nerves of wild-type (open bars) and Sox10
eSC 
(closed bars) embryos was quantified at 14.5, 16.5, and 18.5 dpc and is 
presented as mean ± SEM. At least 15 spinal nerves from two independent 
embryos were counted for both genotypes. Differences were statistically 
significant between wild type and Sox10
eSC mutant from 16.5 dpc on-
wards as determined by Student’s t test (***, P ≤ 0.001). Bars, 50 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   704
dramatic after the third week, with Sox10
eSC mice being 52% 
lighter at P24 and 68% lighter at P32 than their wild-type   
littermates. Sox10
eSC mice looked increasingly runted, and 
locomotion progressively deteriorated. Symptoms included a 
shiverer-type tremor, an abnormal, straddled position of the 
hindlimbs, and poor motor coordination, resulting in an unsteady 
staggering gait. Even when care was taken that Sox10
eSC mice 
had continuous unlimited access to wet chow and drinking 
water, most succumbed to death during the fifth week. The 
few remaining survivors invariably died before the end of the   
seventh week.
Postnatal sciatic nerve development in 
Sox10
eSC mice
To  study  postnatal  peripheral  nerve  development  in  more   
detail, we focused on the sciatic nerve. In contrast to the 
opaque wild-type sciatic nerve, the sciatic nerve of Sox10
eSC 
mice was translucent, appeared less well defined, and lacked 
the characteristic banded pattern (Fig. 4 B). From the third 
week onwards, the mutant sciatic nerve was also signifi-
cantly thinner, with a mean decrease in thickness by 22%   
at  P24  and  by  40%  at  P32,  confirming  the  degenerative   
phenotype (Fig. 4 C).
As observed during late embryogenesis, widespread ex-
pression of Sox2 continued along the sciatic nerve in Sox10
eSC 
mice throughout the analyzed postnatal period, whereas only 
few cells along wild-type nerves were Sox2 positive (Fig. 4,   
D–G; and not depicted). In contrast, Krox20 was only present in 
wild-type sciatic nerves but was missing from Sox10-deficient 
sciatic nerves (Fig. 4, H–K; and not depicted). Neither immuno-
histochemistry nor in situ hybridization detected expression of 
the myelin genes Mpz and Mbp in sciatic nerves of Sox10
eSC 
mice (Fig. 4, L–S; and not depicted). Paraphenylenediamine 
(PPD) staining confirmed the complete absence of myelin within 
the mutant sciatic nerve (Fig. 4, T–W).
that inefficient recombination at the Sox10 locus and slow   
turnover  of  the  Sox10  protein  lead  to  a  significant  delay   
between the onset of Cre activity and the disappearance of 
Sox10. As a consequence, Sox10 protein is still present in im-
mature Schwann cells before eventually being deleted during 
late embryogenesis.
Embryonic Schwann cell development in 
Sox10
eSC mice
As expected from the still widespread occurrence of Sox10 in 
peripheral nerves of Sox10
eSC embryos at 14.5 dpc, Schwann 
cell markers were similarly expressed in wild type and mutant 
(unpublished data). From 16.5 dpc onwards, differences be-
tween the two genotypes became apparent. Whereas Sox2 was 
down-regulated in Schwann cells along wild-type nerves, its ex-
pression continued at high levels in the mutant (Fig. 3, A–D). 
Conversely, many Schwann cells had already entered the pro-
myelinating stage at 16.5 dpc in the wild type and expressed 
Oct6, whereas Oct6 was not expressed in the mutant (Fig. 3,   
G and H). This is not simply a delay, as Oct6 was still absent in 
the mutant at 18.5 dpc (Fig. 3, I and J). Up-regulation of Krox20 
was also not observed at 18.5 dpc in the mutant nerve but was 
clearly visible in the wild type concomitant with the onset of 
myelination  (Fig.  3,  E  and  F).  Strong  expression  of  myelin 
genes such as Mbp or Mpz remained restricted to the wild type 
(Fig. 3, K and L; and not depicted). Thus, the marker gene pat-
tern observed in Sox10
eSC embryos is consistent with Schwann 
cells not progressing beyond the immature stage.
Postnatal development of Sox10
eSC mice
Newborn  Sox10
eSC  mice  were  indistinguishable  from  their 
wild-type littermates but failed to thrive soon after birth. Al-
ready at postnatal day (P) 8, body weight was lower in Sox10
eSC 
than in wild-type pups (Fig. 4 A). Weight differences were   
in the range of 15–25% in the first 2–2.5 wk but became more 
Figure 3.  Expression of Schwann cell markers in peripheral nerves of Sox10
eSC embryos. (A–L) Immunohistochemistry (A–J) and in situ hybridizations   
(K and L) were performed on transverse sections of wild-type (wt; A, C, E, G, I, and K) and Sox10
eSC (B, D, F, H, J, and L) sciatic nerves at 16.5 (A, B,   
G, and H) and 18.5 dpc (C–F and I–L) using antibodies directed against Sox2 (A–D), Krox20 (E and F), Oct6 (G–J), and an antisense riboprobe for Mbp   
(K and L). (C, F, H, and J) Dotted lines indicate the circumference of the sciatic nerve. Bars, 50 µm.705 Sox10 function in Schwann cell development • Finzsch et al.
Cellular turnover in the postnatal sciatic 
nerve of Sox10
eSC mice
In mutant sciatic nerves, the number of cells (quantified as DAPI-
stained nuclei) was not decreased (Fig. 5 A). Both in wild-type 
and mutant sciatic nerve, 220 nuclei were present, on average, 
per section at 18.5 dpc. Whereas this number increased only 
gradually to 460 in the wild type until P24, it reached already 
560 at P8 in the mutant and increased, on average, to a constant 
level of 730 between P16 and P32. Thus, despite being thinner 
from P16 onwards, the mutant sciatic nerve contained signifi-
cantly more cells than the wild type.
This went along with significant increases in the number 
of proliferating cells in the sciatic nerve of Sox10
eSC mice, as 
Altered nerve conduction in Sox10
eSC mice
In agreement with the lack of myelin, compound action poten-
tials of sciatic nerves of 16-d-old Sox10
eSC mice lacked the fast 
component (20 m/s) that originates from conduction along   
myelinated fibers (Fig. 4 X). Instead, action potentials along   
mutant sciatic nerves traveled in two compound waves with 
conduction velocities of 1.3 and 0.65 m/s (Fig. 4 Y). None cor-
responded to the singular slow component in wild-type sciatic 
nerves, which exhibited a velocity of 0.56 m/s and is character-
istic for nonmyelinated type C fibers, arguing that nonmyelin-
ated fibers are affected as well. Furthermore, amplitudes were 
grossly reduced in the mutant. Thus, nerve conduction along the 
sciatic nerve is dramatically altered in Sox10
eSC mice.
Figure 4.  Postnatal development of Sox10
eSC mice 
and their sciatic nerves. (A) Weight of wild-type (open 
bars) and age-matched Sox10
eSC (closed bars) mice 
was monitored at P8, P16, P24, and P32. Data are 
shown as means ± SEM (n ≥ 6 for each genotype). 
Statistically significant differences from wild-type con-
trols were observed from P16 onwards (**, P ≤ 0.01;   
and ***, P ≤ 0.001 by Student’s t test). (B) Macro-
scopic appearance of P32 sciatic nerves from wild-
type (wt) and Sox10
eSC mice. (C) Sciatic nerve 
thickness was quantified for wild-type and Sox10
eSC 
mice at P8, P16, P24, and P32 by determining the 
area on proximal nerve sections. At least 20 sections 
from three mice were used per genotype for quan-
tification. Data are presented as mean ± SEM. Dif-
ferences were statistically significant between wild 
type and Sox10
eSC mutant from P8 onwards as de-
termined by Student’s t test (**, P ≤ 0.01; ***, P ≤ 
0.001). (D–K) Immunohistochemistry was performed 
on sciatic nerve sections from wild-type (D, F, H, and J) 
and Sox10
eSC (E, G, I, and K) mice at P16 (D, E, 
H, and I) and P32 (F, G, J, and K) using antibodies 
directed against Sox2 (D–G) and Krox20 (H–K).   
(D, F, I, and K) Dotted lines indicate the circumfer-
ence of the sciatic nerve. (L–S) In situ hybridization 
was performed on sciatic nerve sections from wild-
type (L, N, P, and R) and Sox10
eSC (M, O, Q, and S)   
mice at P16 (L, M, P, and Q) and P32 (N, O, R, and S) 
using antisense riboprobes for Mpz (L–O) and Mbp 
(P–S). (T–W) Myelin sheaths were visualized by PPD 
staining of sciatic nerve sections from wild-type (T and V)   
and Sox10
eSC (U and W) mice at P16 (T and U)   
and P32 (V and W). (X and Y) Electrophysiology on 
sciatic nerves of Sox10
eSC mice. Compound action 
potentials were monopolarly recorded from isolated 
sciatic nerves of wild-type and Sox10
eSC mice (n = 2 
each). Experiments were performed on both nerves   
of  each  animal  with  identical  results  within  each 
genotype.  Representative  superimposed  traces  are 
presented for both genotypes showing fast nerve 
conduction along myelinated fibers (X) and slow con-
duction along nonmyelinated fibers (Y). The arrows 
point to components of different conduction veloci-
ties (meters/second). Bars: (B) 1 mm; (D–S) 50 µm; 
(T–W) 3 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   706
their transiently increased proliferation is counteracted by   
increased apoptosis.
Other major cell types within the peripheral nerve include 
endothelial cells, pericytes, endoneurial fibroblasts, perineurial 
cells, and cells of the immune system. Immunohistochemistry 
with antibodies against Pecam revealed a strong increase in the 
number of cells (Fig. 7, A–D). In the peripheral nerve, Pecam is 
expressed in several cell types (Berman et al., 1996). However, 
80–90% of the Pecam-positive cells were also labeled in wild-
type and mutant nerve with antibodies directed against von   
Willebrand factor (Fig. 7, C and D), identifying the majority as 
endothelial cells. This increase in endothelial cells was accom-
panied by a comparable increase in pericytes, as evident from 
immunohistochemistry with desmin antibodies (Fig. 7, E–H). 
Pecam antibodies also stained the perineurial sheath in the wild 
type (Fig. 7 A). It is unclear whether this staining is specific. 
However, its absence in the mutant (Fig. 7 B) is indicative of 
structural alterations in the perineurial sheath of nerves from 
Sox10
eSC mice (see next section). Perineurial cells were present 
in the mutant sciatic nerve, as transcript levels for the peri-
neurial cell marker Occludin were comparable to the wild type 
(unpublished data). Unfortunately, we did not manage to visual-
ize these cells directly, as none of the antibodies against the few 
available markers for this cell type worked in our hands. Simi-
larly, there is no robust specific immunohistochemical marker 
for endoneurial fibroblasts. Using antibodies against Iba1, we 
detected a substantial increase in macrophages in the sciatic 
nerve of Sox10
eSC mice (Fig. 7, I and J). T lymphocytes were 
also significantly increased, as evident from anti-CD3 stainings 
(Fig. 7, K and L).
By quantifying the immunohistochemical stainings, we 
determined the relative contribution of each cell type to the   
total cell population within wild-type and mutant sciatic nerve 
from P16 to P32. As evident from Fig. 7 (M–O), not only endo-
thelial cells, pericytes, macrophages, and T lymphocytes in-
creased in number, but also the cells that were not labeled   
by any of the cell type–specific markers. These include peri-
neurial cells and endoneurial fibroblast as well as some adipo-
cytes in case of the mutant (see next section). Thus, cellular 
composition is severely altered in postnatal sciatic nerves of 
Sox10
eSC mice.
determined by Ki67 immunoreactivity (Fig. 5 B). In the wild-
type sciatic nerve, the number of Ki67-positive cells continu-
ously decreased during the first postnatal weeks from a maximum 
of 50 cells per section at P8 to <7 from P16 onwards. In con-
trast, the mutant nerve contained 80 Ki67-positive cells at 
P8 and >50 at P16. A substantial decrease of Ki67-positive 
cells was not observed before P24 in the mutant sciatic, but 
even then, numbers remained higher than in the wild type   
(Fig. 5 B). From P16 onwards, apoptotic cells as determined 
by TUNEL were also significantly increased in sciatic nerves 
of Sox10
eSC mice relative to the wild type (Fig. 5 C). How-
ever, the absolute number of apoptotic cells per section re-
mained fairly low.
Cellular composition in the postnatal 
sciatic nerve of Sox10
eSC mice
To find out whether Schwann cells increased in numbers, we 
quantified Sox2-positive cells in the sciatic nerves of Sox10
eSC 
mice. Their absolute number increased only slightly from P8 
until P32 (Fig. 6 A). As a consequence, the contribution of 
Sox2-positive cells to the total cell population remained <30% 
in the mutant sciatic nerve (Fig. 6 B).
Sox2 may not label all cells of the Schwann cell lineage 
in peripheral nerves of Sox10
eSC mice. Therefore, we per-
formed lineage tracing elements by additionally introducing the   
Rosa26
stopfloxYFP allele into the Sox10
eSC mice. In these mice, 
YFP is expressed in all cells along the nerve that at one time ex-
pressed Dhh::Cre. The number of YFP-expressing cells along 
the peripheral nerve of Sox10
eSC mice did not significantly in-
crease from P8 to P32 and closely matched the number of Sox2-
expressing cells (Fig. 6 C). Coimmunohistochemistry confirmed 
that the vast majority of YFP-expressing cells were also Sox2 
positive and vice versa (Fig. 6, D–G). Direct comparison of the 
proliferation rate of YFP-expressing cells with similarly YFP-
labeled cells in the wild type revealed that it was significantly 
elevated in peripheral nerves of Sox10
eSC mice only at P16 
(Fig. 6 H). Furthermore, YFP-expressing cells accounted from 
P8 to P24 for a smaller fraction of the proliferating cells in the 
mutant than in the wild type (Fig. 6 I). This argues that the 
Schwann cell lineage is not predominantly responsible for the 
increased cell numbers in the mutant sciatic nerves and that 
Figure 5.  Proliferation and cell death in sciatic nerves of Sox10
eSC mice. (A) The total cell number in sciatic nerves was determined for wild-type and 
Sox10
eSC mice at 18.5 dpc, P8, P16, P24, and P32 by quantifying the DAPI-stained nuclei in proximal nerve sections. (B) Proliferative cells were counted 
in wild-type and Sox10
eSC sciatic nerves at P8, P16, P24, and P32 as Ki67-positive cells. (C) Cell death was measured by the number of TUNEL-positive 
cells in wild-type and Sox10
eSC sciatic nerves at P16, P24, and P32. For all quantifications, at least 20 sections from three mice were used per genotype. 
Data are presented as mean ± SEM. According to the Student’s t test, differences were statistically significant between wild type and Sox10
eSC mutant as 
indicated (**, P ≤ 0.01; ***, P ≤ 0.001).707 Sox10 function in Schwann cell development • Finzsch et al.
Their increased protein synthesis likely contributes to the extra 
collagen and elastic fibers in Sox10
eSC mice. Compared with 
the thick and continuous basal lamina of wild-type Schwann 
cells (Fig. 8 E), the basal lamina of Schwann cells in Sox10
eSC 
mice was considerably thinner and often incomplete (Fig. 8 F). 
Axons in mutant sciatic nerves contained microtubules, neuro-
filaments, and mitochondria (Fig. 8 D) and showed no ob-
vious differences in ultrastructure to wild-type axons (Fig. 8 C). 
Signs of axonopathy were not observed in the mutant sciatic 
nerve, and motor neuron numbers in the ventral horn of the 
spinal cord were unaffected (unpublished data). The presence 
of  adipocytes  with  lipid  inclusions  in  sciatic  nerves  was 
unique to the mutant (Fig. 8 B, asterisks). When compared with 
the wild type, the perineurial sheath was dramatically thinned 
(Fig. 8, G and H).
Compared with P16, myelinated axons and Remak bundles 
in wild-type nerves were less tightly grouped together at P32 and 
separated by loose endoneural extracellular matrix (Fig. 9 A). 
Both structures were still absent at P32 in mutant sciatic nerves, 
and the dense fibrillar extracellular matrix had expanded even 
further (Fig. 9 B). Many axon bundles were no longer completely 
surrounded by a Schwann cell and its processes (Fig. 9 C, white 
arrows) but were in direct contact with collagen fibrils and elas-
tic fibers in the surrounding extracellular matrix (Fig. 9 C, asterisk). 
Several Schwann cells were observed in mutant sciatic nerves 
Nerve ultrastructure in Sox10
eSC mice
To define ultrastructural changes in mutant sciatic nerves, we 
performed electron microscopy at P16 and P32. In wild-type 
sciatic nerves, large-caliber axons were heavily myelinated   
at P16 (Fig. 8 A). This was not the case in sciatic nerves of 
Sox10
eSC mice (Fig. 8 B). Remak bundles, in which a non-
myelinating Schwann cell is associated with many small diameter 
axons and surrounds each and every axon with its membrane, 
were also present in wild-type nerves (Fig. 8 A, arrows) but 
missing in Sox10
eSC mice (Fig. 8 B). Instead, large- and small-
caliber axons were tightly grouped together in mutant nerves 
and jointly surrounded by a single Schwann cell and its pro-
cesses (Fig. 8 B). Such a configuration is characteristic of the 
immature Schwann cell stage in which axonal sorting and es-
tablishment of a 1:1 ratio of Schwann cells with large diame-
ter axons has not yet taken place (Jessen and Mirsky, 2005).   
In mutant sciatic nerves, a dense layer of collagen and elastic   
fibers was present around each group of axons and associated 
Schwann cell (Fig. 8 D; for higher magnification of elastic   
fibers see Fig. 8 F). This was again surrounded in an onion skin 
style by one or two layers of flat cells with long cytoplasmic 
processes (Fig. 8 D, black arrows). Furthermore, a consider-
able number of Schwann cells in the mutant exhibited unusu-
ally high amounts of rough endoplasmic reticulum (Fig. 8 D, 
white arrows) and resembled fibroblasts in their appearance. 
Figure 6.  Schwann cell proliferation in sciatic nerves 
of Sox10
eSC mice. (A and B) The absolute number of 
Sox2-positive cells was determined in sciatic nerves of 
Sox10
eSC mice at P8, P16, P24, and P32 (A) and set in 
relation to the total number of cells (B). (C) Cell numbers 
were  also  determined  for  YFP-expressing  cells  in  sci-
atic nerves of Dhh::Cre, Rosa26
stopfloxYFP (Rosa26
DhhYFP; 
open  bars)  and  Dhh::Cre,  Sox10
fl/fl,  Rosa26
stopfloxYFP 
mice (Sox10
eSC, Rosa26
DhhYFP; closed bars) at P8, P16, 
P24,  and  P32.  (D–G)  Coimmunohistochemistry  was 
performed  on  sciatic  nerve  sections  of  Sox10
eSC,   
Rosa26
DhhYFP mice at P8 (D), P16 (E), P24 (F), and P32 (G) 
using antibodies against Sox2 (red) and YFP (green). 
(H) Proliferation rates of wild-type (wt) and Sox10
eSC 
Schwann cells were determined at P8, P16, P24, and 
P32 by determining the fraction of Ki67-positive cells 
among the YFP-labeled cells in Rosa26
DhhYFP (open bars) 
and Sox10
eSC, Rosa26
DhhYFP mice (closed bars). (I) The 
proliferation rates of Sox10
eSC Schwann cells (see H) 
were also used to determine the relative contribution 
of Schwann cells to the overall proliferation in sciatic 
nerves of Sox10
eSC mice. For all quantifications, at least 
20 sections from three mice were used per genotype. 
Data are presented as mean ± SEM. According to the 
Student’s t test, differences were statistically significant 
between wild type and Sox10
eSC mutant as indicated 
(**, P ≤ 0.01; ***, P ≤ 0.001). Bars, 10 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   708
To obtain these results, we generated a conditional Sox10 allele 
and deleted it with a Dhh::Cre transgene. This transgene has 
previously been reported to become active already in Schwann 
cell precursors (Jaegle et al., 2003). Nevertheless, all available 
morphological data and marker gene studies indicate that it is 
not before the immature Schwann cell stage that most Schwann 
cells lose Sox10 protein.
Sox10 is expressed at high levels during Schwann cell de-
velopment. Therefore, if stable, it may take a while before cells 
become Sox10 negative even if the gene is already deleted in the 
Schwann cell precursor. Alternatively, the loxP sites in the 
Sox10 allele may not be easily accessible to Cre recombinase in 
Schwann cells or recombine with fairly low efficiency for other 
reasons. In fact, slow protein turnover and inefficient recom-
bination both seem to contribute, as Sox10 protein is lost at a 
significantly slower pace than Sox10 transcripts, which in 
turn persist longer than it takes for the Rosa26
stopfloxYFP allele   
to recombine.
Because Schwann cells do not lose Sox10 protein before 
the immature stage, we cannot answer whether Sox10 is re-
quired in Schwann cell precursors to allow progression into 
immature Schwann cells. What we can conclude is that imma-
ture Schwann cells depend on the presence of Sox10 to de-
velop into myelinating as well as nonmyelinating Schwann 
cells. As a consequence, large- and small-caliber axons remain 
jointly bundled in nerves from Sox10
eSC mice. In the absence 
of myelination and axonal sorting, fast nerve conduction is 
missing, and conduction in nonmyelinated fibers is grossly   
altered. The absence of myelinating as well as nonmyelinating 
that showed condensed and fragmented chromatin indicative of 
apoptotic cell death (Fig. 9 D, asterisk).
Gene expression of Schwann cells in the 
postnatal sciatic nerve of Sox10
eSC mice
The fact that Schwann cells possessed only a poorly developed 
basal lamina, exhibited a distended endoplasmic reticulum, and, 
in some instances, had loosened the contact to their associated 
axon bundle by P32 is evidence that these cells had lost some of 
their typical features. To characterize the mutant Schwann cells 
in greater detail, we also analyzed their expression pattern by 
comparing transcript levels for Schwann cell markers in wild-
type and mutant sciatic nerves by quantitative RT-PCR at P16. 
Myelin gene expression was used as a control and was indeed 
dramatically reduced in the mutant relative to the wild type 
(Fig. 10, A and B). In contrast, c-Jun expression was strongly up-
regulated in the mutant (Fig. 10 C). This was expected, as c-Jun 
and Sox2 are both characteristic of the immature Schwann cell 
stage (Jessen and Mirsky, 2005). However, surprisingly, there was 
also a dramatic down-regulation of Dhh, S100-, and ErbB3, 
which should all be expressed in the immature Schwann cell stage 
(Fig. 10, D–F). This indicates that Schwann cells had not main-
tained their normal expression pattern in the absence of Sox10.
Discussion
In this study, we show that Sox10 is not only required for 
Schwann cell specification but also at later stages for maintain-
ing Schwann cell identity and proper lineage progression.   
Figure  7.  Cellular  composition  of  sciatic  nerves  in 
Sox10
eSC mice. (A–L) Immunohistochemistry was per-
formed on sciatic nerve sections from wild-type (wt; A, 
C, E, G, I, and K) and Sox10
eSC (B, D, F, H, J, and L) 
mice at P16 using antibodies directed against Pecam 
(A–D) and von Willebrand factor (vWF; C and D) as 
predominantly endothelial markers, desmin (E–H) as 
a marker for pericytes, Iba1 (I and J) as a marker for   
macrophages, and CD3 (K and L) as a marker for T lym-
phocytes and is shown in low (A, B, E, and F) and high   
(C, D, and G–L) magnification. All markers are in red ex-
cept Pecam, to which green color was assigned. Nuclei 
in C, D, and G–L were counterstained by DAPI (blue). 
(M–O) These and analogous experiments at other time 
points were used to determine the cellular composition 
of sciatic nerves in wild-type and Sox10
eSC mice at 
P16 (M), P24 (N), and P32 (O). Quantifications were 
performed on at least 20 sections from three mice per 
genotype. Cell numbers are presented as mean ± SEM. 
Bars: (A, B, E, and F) 50 µm; (C, D, and G–L) 10 µm.709 Sox10 function in Schwann cell development • Finzsch et al.
Nodari et al., 2007; Kao et al., 2009). However, in Nfat1c  
mutants, the effect on axonal sorting is much less pronounced 
(Kao et al., 2009). In contrast, Schwann cell–specific Rac1 mu-
tants exhibit major but not complete myelination and axonal sort-
ing defects. In contrast to our mouse model, quite a bit of normal 
myelin appears in Rac1 mutants at older ages (Benninger et al., 
2007). Complete disruption of axonal sorting was observed in 
Schwann cell–specific 1 integrin mutants, and there is evidence 
that Rac1 functions downstream of 1 integrin (Feltri et al., 2002; 
Nodari et al., 2007). In this respect, Schwann cell–specific 1   
integrin mutants resemble our Sox10
eSC mice phenotypically. 
However, the underlying defect is different, as 1 integrin ex-
erts its main influence directly on the interaction of Schwann 
cells with axons, whereas Sox10 rather influences cell identity 
and lineage progression.
Loss of Sox10 in immature Schwann cells did not negatively 
affect their proliferation. We even observed a slight transient in-
crease in Schwann cell proliferation rates during the first postnatal 
weeks. However, this was counteracted by simultaneous mild   
increases in apoptosis. We conclude from these findings that 
Sox10 does not primarily function in immature Schwann cells   
as a proliferation or cell survival factor. Thus, Sox10
eSC mice are 
different from Schwann cell–specific Cdc42 mutants in which 
Schwann cell proliferation is significantly decreased (Benninger 
et al., 2007).
Schwann cells may be one reason for the severity of the result-
ing phenotype. In contrast, defects are largely restricted to 
myelinating Schwann cells in the Oct6- and Krox20-null mu-
tants (Topilko et al., 1994; Bermingham et al., 1996; Jaegle   
et al., 1996) as well as the various myelin gene mutants (for 
review see Martini, 1997). In these mutants, axonal sorting 
occurs, and Schwann cells progress at least into the promyelin-
ating stage, where they establish a 1:1 ratio with large-caliber 
axons and wrap one turn and a half of their plasma membrane 
around the axon.
However, there is also a set of mutants in which additional 
sorting defects occur. These include the Nfat1c, Rac1, and 1 
integrin mouse mutants (Feltri et al., 2002; Benninger et al., 2007; 
Figure 8.  Sciatic nerve ultrastructure in Sox10
eSC mice at P16. (A–H) My-
elin sheaths and Remak bundles (white arrows in A) were only present in 
wild-type nerves (A, C, E, and G), whereas large- and small-caliber axons 
were jointly surrounded by a single Schwann cell in nerves of Sox10
eSC 
mice (B, D, F, and H). Collagen and elastic fibers were densely layered 
around each group of axons and associated Schwann cell in mutant sci-
atic nerves, again surrounded in an onion skin style by flat cells with long 
cytoplasmic processes (black arrows in D). Adipocytes with lipid inclusions 
(asterisks in B) were present in mutant sciatic nerves and Schwann cells 
frequently had an enlarged rough endoplasmic reticulum (white arrows 
in D). Axons in mutant and wild-type sciatic nerves looked similar. Myelin 
sheaths in wild-type nerves were surrounded by a complete basal lamina 
(black arrows in E). In contrast, in nerves of Sox10
eSC mice the basal 
lamina of Schwann cells was considerably thinner and often incomplete 
(black arrows in F). In addition, elastic fibers (white arrow in F) were fre-
quently observed in close contact with Schwann cells of mutant nerves but 
were essentially absent in wild-type nerves. The perineurial sheath was dra-
matically thicker in wild-type nerves (bracket in G) than in mutant nerves 
(bracket in H). Bars: (A) 2 µm; (B) 5 µm; (C and D) 1 µm; (E–H) 500 nm.
Figure 9.  Sciatic nerve ultrastructure in Sox10
eSC mice at P32. (A) My-
elinated axons and Remak bundles in wild-type sciatic nerves were sepa-
rated by loose endoneural extracellular matrix. (B) In mutant nerves, axon 
bundles and their associated Schwann cells were separated from other 
units by a dense fibrillar extracellular matrix. (C) Axon bundles in mutant 
nerves were frequently not completely covered by a Schwann cell and 
its processes (white arrows) but in direct contact to the surrounding extra-
cellular matrix which contains collagen fibrils (black arrow) and elastic 
fibers (asterisk). (D) Several Schwann cells in mutant sciatic nerves show 
condensed and fragmented chromatin (asterisk), strongly indicating apop-
totic cell death. Bars: (A and B) 2.5 µm; (C) 250 nm; (D) 1 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   710
De Vries, 2007). In Sox10
eSC mice, increased Schwann cell 
expression of proangiogenic factors may thus promote vasculo-
genesis, whereas heightened chemokine production may attract 
macrophages, which in turn help to recruit T lymphocytes to the 
mutant nerve (Martini et al., 2008). This offers a plausible ex-
planation for the origin of the altered cellular composition in 
mutant sciatic nerves.
Altered gene expression in the immature Sox10-deficient 
Schwann cells can also be inferred from the poorly developed 
basal lamina and their strong overall increase of protein syn-
thesis in Sox10
eSC mice. At least some of this synthesis can   
be attributed to the production of collagen fibrils and elastin-
containing fibers. Furthermore, mutant Schwann cells loosened 
their contact with axons and became more fibroblast-like in ap-
pearance. Our study supports the notion that Schwann cells are 
unable to maintain their full identity and acquire some charac-
teristics that are normally associated with fibroblasts. However, 
we do not suggest that mutant Schwann cells fully transform 
into fibroblasts. Previous experiments have indicated that a 
small percentage of neural crest cells in peripheral nerves give 
rise to endoneurial fibroblasts, whereas the majority develops 
into Schwann cells (Joseph et al., 2004). No single marker ex-
ists that identifies these endoneurial fibroblasts unequivocally. 
Thus,  the  relationship  between  our  mutant  Schwann  cells   
and these neural crest–derived endoneurial fibroblasts remains 
unclear at present.
Our findings also have important implications for human 
pathology. Several reported SOX10 mutations cause peripheral 
neuropathies in the heterozygous state (Inoue et al., 2004). Such 
neuropathies are not detected in mice with a single functional 
Sox10 allele and are likely caused by the dominant action of the 
mutant human SOX10 protein. Our results now show that this 
dominant action may not only affect the Schwann cell specifica-
tion process but may also interfere with the normal function of 
Sox10 during further lineage progression.
Materials and methods
Construction of targeting vectors, gene targeting, generation, and 
genotyping of mouse mutants
To generate a conditional Sox10 allele, the ORF for rat Sox10 was placed 
between 5 and 3 Sox10 genomic regions as homology arms (4.3 kb and 
1.5 kb, respectively) in the context of a pPNT vector backbone in such a way   
that the start codon of the ORF was placed exactly at the position of the endog-
enous ATG in exon 3 (Britsch et al., 2001; Ludwig et al., 2004; Kellerer 
et al., 2006). The targeting vector thereby replaced the Sox10 coding exons 
by a continuous Sox10 reading frame. Additionally, a neomycin resistance 
cassette with flanking loxP and Flp recognition target (FRT) sites and a linked 
IRES-EGFP cassette were placed immediately behind the Sox10 ORF using a 
SalI restriction site. Finally, another loxP site was introduced into a StuI site 
394 bp in front of the splice acceptor site in intron 2 in the same orientation 
as the ones flanking the neomycin resistance cassette (Fig. 1 A). The con-
struct was linearized with SspI and electroporated into embryonic day 14.1 
ES cells, which were then selected with 400 µg/ml G418 and 2 µM ganci-
clovir. Selected ES cell clones were screened by Southern blotting as 
described previously (Schreiner et al., 2007). Two targeted ES cell lines   
carrying the Sox10
flneo allele (Fig. 1 A) were injected into C57BL/6J blasto-
cysts to generate chimeras. Chimeric males from two independent clones 
were crossed to FLPe deleter mice (Rodríguez et al., 2000) to achieve germ-
line transmission and simultaneous FRT-mediated deletion of the neomycin 
resistance cassette. As a result, heterozygous mice with a Sox10
fl allele were 
obtained (Fig. 1 A). Structural integrity of the Sox10
fl allele was confirmed 
by Southern blot experiments with a 0.6-kb 5 probe, which recognized a 
Sox10 rather appears to be important in immature Schwann 
cells for lineage progression as neither Oct6 nor Krox20 was in-
duced in these cells in the absence of Sox10. This agrees with 
previous reports of a direct dependence of Krox20 expression on 
Sox10 (Ghislain and Charnay, 2006; Kao et al., 2009; Reiprich   
et al., 2010) and predicts that Oct6 expression is also dependent 
on Sox10, either directly or indirectly.
In addition to its requirement for lineage progression, 
Sox10 is also needed to maintain the identity of immature 
Schwann cells. In the absence of Sox10, immature Schwann   
cells lose expression of some of their typical markers, including   
S100- and Dhh. Schwann cell–derived Dhh has previously 
been reported to be essential for perineurial sheath formation 
(Parmantier et al., 1999). Thus, its loss may explain the dramati-
cally thinned perineurial sheath in peripheral nerves of Sox10
eSC 
mice. An additional reduction in ErbB3 expression may con-
tribute to the inability of mutant immature Schwann cells to fur-
ther mature. Dependency of ErbB3 expression on Sox10 has 
already been reported for earlier periods of Schwann cell devel-
opment (Britsch et al., 2001).
By expression profiling, we also found up-regulation of the 
proangiogenic factors angiopoietin 1 and vascular endothelial 
growth factor C, the monocyte chemoattractant Ccl8, and the 
macrophage  chemoattractants  Ccl6  and  Cxcl14  in  peripheral 
nerves of Sox10
eSC mice (unpublished data). In nerves, Cxcl14 is 
predominantly expressed in Schwann cells, and expression levels 
appear to correlate with less differentiated or pathological states 
(Barbaria et al., 2009). Angiopoietin 1 and vascular endothelial 
growth factor C have also been detected in Schwann cells, 
and higher expression in neurofibromin-deficient Schwann cells 
was associated with increased vasculogenesis (Thomas and 
Figure 10.  Gene expression experiments on sciatic nerves of Sox10
eSC 
mice. (A–F) Quantitative RT-PCR was performed on cDNA prepared from 
P16 sciatic nerves of wild-type (open bars) and Sox10
eSC (closed bars) 
mice using primers directed against Mbp (A), Mpz (B), c-Jun (C), Dhh (D),   
S100- (E), and ErbB3 (F). Transcript levels in each sample were nor-
malized to Rpl8. After normalization, transcript levels in the wild type 
were arbitrarily set to 1, and transcript levels in Sox10
eSC mice are ex-
pressed relative to wild-type levels ± SEM. Experiments were repeated 
twice with material from two independent sciatic nerve preparations for 
each genotype.711 Sox10 function in Schwann cell development • Finzsch et al.
For  immunohistochemistry,  the  following  primary  antibodies  were 
used in various combinations: anti-Sox10 guinea pig antiserum (1:1,000; 
Maka et al., 2005), anti-Oct6 rabbit antiserum (1:2,000; Friedrich et al., 
2005), anti-Krox20 rabbit antiserum (1:200; Covance), anti-Sox2 rabbit   
antiserum (1:500), anti-Ki67 rabbit antiserum (1:500; Thermo Fisher Scien-
tific), anti-CD3 rabbit antiserum (1:500; Abcam), anti-GFP rabbit antiserum 
(1:500; Invitrogen), anti-Iba1 rabbit antiserum (1:250; Wako Chemicals 
USA, Inc.) antidesmin rabbit antiserum (1:1,000; Abcam), anti–von Wille-
brand factor rabbit antiserum (1:800; Abcam), and anti-PECAM rat anti-
serum (1:200; BD). Secondary antibodies conjugated to Cy2, Cy3, or Alexa 
Fluor 488 immunofluorescent dyes (Dianova) were used for detection. Micro-
graphs were taken from a microscope (DM-IRB; Leica) equipped with 10× 
NA 0.3 or 20× NA 0.5 HC PL Fluotar objectives at room temperature in air 
as imaging medium using a charge-coupled device camera (SPOT model 
1.3.0; Diagnostic Instruments, Inc.) and IP Laboratory (Scanalytics) as acqui-
sition software. All images were processed using Photoshop CS2 (Adobe).
Histology and electron microscopic analysis
Mice were anaesthetized and perfused transcardially using 0.9% NaCl solu-
tion followed by 1% glutaraldehyde and 2.5% paraformaldehyde in 0.1 M 
Na cacodylate buffer, pH 7.5. Sciatic nerves were dissected and underwent 
overnight fixation at 4°C in cacodylate-buffered fixative containing 2.5% 
paraformaldehyde and 2.5% glutaraldehyde. After extensive washing in 
0.1 M Na cacodylate, pH 7.3, tissues were postfixed in cacodylate-buffered 
1% osmium ferrocyanide for 2 h, dehydrated in an ascending ethanol series, 
and embedded in Epon resin. For light microscopy, semithin sections (1-µm 
thickness) were stained with PPD (Estable-Puig et al., 1965). Micrographs 
were taken from a microscope (DMR; Leica) equipped with a 40× NA 0.75 
HCX PL Fluotar objective at room temperature in air as imaging medium   
using a camera (AxioCam MRc; Carl Zeiss, Inc.) and Axio Vision as acquisi-
tion software. For electron microscopy, ultrathin sections (50-nm thickness) 
were stained with uranyl acetate and lead citrate and examined with an 
electron microscope (Libra; Carl Zeiss, Inc.; Friedrich et al., 2005).
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yielded the genotypes analyzed in this study. Genotyping was routinely per-
formed on DNA from tail tips or, in case of embryos, from yolk sacs by PCR 
analysis. Primers for the Dhh::Cre transgene and the Rosa26
stopfloxYFP allele 
were as described previously (Srinivas et al., 2001; Jaegle et al., 2003). For 
Sox10 genotyping, we used an upper primer located 81 bp upstream of the 
start codon (5-CAGGTGGGCGTTGGGCTCTT-3) and two lower primers 
located 487 bp downstream of the start codon in intron 3 of the Sox10 gene   
(5-TCCCAGGCTAGCCCTAGTG-3) or 617 bp downstream of the start   
codon in the Sox10 reading frame (5-GTGAGCCTGGATAGCAGCAG-3). 
Genotyping revealed a 568-bp fragment for the wild-type allele and a 698-bp 
fragment in the case of the Sox10
fl allele (Fig. 1 C).
Electrophysiology
Animals were sacrificed in a pure CO2 atmosphere, and the sciatic nerves of 
both legs were excised from the trifurcation up to the lumbar plexus and stored 
in carbogen-gased physiological buffer. Compound action potentials were re-
corded monopolarly in a Perspex chamber filled with fluorocarbon oil (FC-43; 
3M Company) at 38°C temperature. The distal end of the isolated nerve was 
electrically stimulated through gold wire electrodes using a voltage-constant 
stimulus isolator and supramaximal intensities: 1 V at 0.1 ms for myelinated 
nerve fibers and 12 V at 1 ms for nonmyelinated ones. Gold wire electrodes   
and a custom-made differential amplifier were used for recording and filter-
ing (1–5,000 Hz), and the output was digitized (DAP 1200; Microstar)   
and stored in a PC using the Spike/Spidi software package (Forster and 
Handwerker, 1990).
RNA preparation from embryos or adult sciatic nerves for  
quantitative RT-PCR
Embryos were obtained from staged pregnancies at 12.5 dpc, and sciatic 
nerves were prepared from 16-d-old mice. Both were processed for RNA iso-
lation using TRIZOL reagent (Invitrogen).
Reverse transcription was performed in a 25-µl reaction using 2 µg   
RNA,  oligo  (dT)  primers,  and  Moloney  murine  leukemia  virus  reverse 
transcription (New England Biolabs, Inc.). Quantitative polymerase chain re-
action with 0.2 µl of the obtained cDNA was performed on a LightCycler   
(Roche)  according  to  the  manufacturer’s  instructions  using  the  ABsolute 
QPCR SYBR green mix (Thermo Fisher Scientific) with an annealing tem-
perature of 60°C. Rpl8 transcripts were used for normalization (Kellerer   
et al., 2006). The following primers were used: 5-ACCCCCACTCAGTTCTT-
GTG-3 and 5-AGTTGCTGAGGTTGGCGTAG-3 for c-Jun, 5-CATGTG-
GCCCGGAGTACGCC-3 and 5-CGCTGCATCAGCGGCCAGTA-3 for   
Dhh, 5-GAGCGGGGTGACGGGAGTAA-3 and 5-GGGTCGCGAACA-
GTTCTCCC-3 for ErbB3, 5-CCAAGTTCACCCCTACTCCA-3 and 5-TA-
AGTCCCCGTTTCCTGTTG-3 for Mbp, 5-CTGGTCCAGTGAATGGGTCT-3   
and 5-CATGTGAAAGTGCCGTTGTC-3 for Mpz, 5-GACTGGGTCAG-
GGAATATCCACC-3 and 5-AGCAGCAGCCATGTACTCTTCAC-3 for 
Occludin, 5-GACTCCAGCAGCAAAGGTGAC-3 and 5-CATCTTCGTC-
CAGCGTCTCCA-3 for S100-, and 5-CAGGTGTGGCTCTGCCCACG-3 
and 5-GTGTAGAGGGGCCGCTGGGA-3 for Sox10.
In situ hybridization and immunohistochemistry
Embryos were obtained from staged pregnancies at 12.5, 14.5, 16.5, 
and 18.5 dpc, and sciatic nerves were obtained from postnatal mice at 
various  ages.  After  fixation  in  4%  paraformaldehyde,  specimens  were 
cryoprotected by overnight incubation at 4°C in 30% sucrose and embed-
ded in tissue-freezing medium (Leica) compound at 80°C. Frozen sec-
tions were prepared at 14-µm thickness and used for in situ hybridizations 
or at 10-µm thickness and used for immunohistochemistry.
In  situ  hybridizations  were  performed  using  digoxigenin-labeled   
antisense riboprobes for Sox10, Mbp, and Mpz as described previously 
(Britsch et al., 2001; Stolt et al., 2002). Micrographs were taken from a 
stereomicroscope (MZ FLIII; Leica) equipped with a 10× Plan-Apochromat 
objective at room temperature in air as imaging medium using a camera 
(AxioCam HRc; Carl Zeiss, Inc.) and Axio Vision (Carl Zeiss, Inc.) as acqui-
sition software.JCB • VOLUME 189 • NUMBER 4 • 2010   712
Martini, R., S. Fischer, R. López-Vales, and S. David. 2008. Interactions between 
Schwann cells and macrophages in injury and inherited demyelinating 
disease. Glia. 56:1566–1577. doi:10.1002/glia.20766
Nodari, A., D. Zambroni, A. Quattrini, F.A. Court, A. D’Urso, A. Recchia, V.L. 
Tybulewicz, L. Wrabetz, and M.L. Feltri. 2007. 1 integrin activates Rac1 
in Schwann cells to generate radial lamellae during axonal sorting and 
myelination. J. Cell Biol. 177:1063–1075. doi:10.1083/jcb.200610014
Paratore, C., D.E. Goerich, U. Suter, M. Wegner, and L. Sommer. 2001. Survival 
and glial fate acquisition of neural crest cells are regulated by an inter-
play between the transcription factor Sox10 and extrinsic combinatorial 
signaling. Development. 128:3949–3961.
Parmantier, E., B. Lynn, D. Lawson, M. Turmaine, S.S. Namini, L. Chakrabarti, 
A.P. McMahon, K.R. Jessen, and R. Mirsky. 1999. Schwann cell-derived 
Desert hedgehog controls the development of peripheral nerve sheaths. 
Neuron. 23:713–724. doi:10.1016/S0896-6273(01)80030-1
Peirano, R.I., D.E. Goerich, D. Riethmacher, and M. Wegner. 2000. Protein zero 
gene expression is regulated by the glial transcription factor Sox10. Mol. 
Cell. Biol. 20:3198–3209. doi:10.1128/MCB.20.9.3198-3209.2000
Pingault, V., N. Bondurand, K. Kuhlbrodt, D.E. Goerich, M.-O. Préhu, A. Puliti, 
B. Herbarth, I. Hermans-Borgmeyer, E. Legius, G. Matthijs, et al. 1998. 
SOX10 mutations in patients with Waardenburg-Hirschsprung disease. 
Nat. Genet. 18:171–173. doi:10.1038/ng0298-171
Reiprich, S., J. Kriesch, S. Schreiner, and M. Wegner. 2010. Activation of Krox20 
gene expression by Sox10 in myelinating Schwann cells. J. Neurochem. 
112:744–754. doi:10.1111/j.1471-4159.2009.06498.x
Rodríguez, C.I., F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, 
A.F.  Stewart,  and  S.M.  Dymecki.  2000.  High-efficiency  deleter  mice 
show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25:139–140. 
doi:10.1038/75973
Schreiner,  S.,  F.  Cossais,  K.  Fischer,  S.  Scholz,  M.R.  Bösl,  B.  Holtmann,   
M. Sendtner, and M. Wegner. 2007. Hypomorphic Sox10 alleles reveal 
novel protein functions and unravel developmental differences in glial 
lineages. Development. 134:3271–3281. doi:10.1242/dev.003350
Southard-Smith, E.M., L. Kos, and W.J. Pavan. 1998. Sox10 mutation disrupts 
neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 
18:60–64. doi:10.1038/ng0198-60
Srinivas, S., T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and 
F.  Costantini.  2001.  Cre  reporter  strains  produced  by  targeted  inser-
tion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1:4. 
doi:10.1186/1471-213X-1-4
Stolt, C.C., S. Rehberg, M. Ader, P. Lommes, D. Riethmacher, M. Schachner,   
U. Bartsch, and M. Wegner. 2002. Terminal differentiation of myelin-
forming  oligodendrocytes  depends  on  the  transcription  factor  Sox10. 
Genes Dev. 16:165–170. doi:10.1101/gad.215802
Thomas, S.L., and G.H. De Vries. 2007. Angiogenic expression profile of normal 
and  neurofibromin-deficient  human  Schwann  cells.  Neurochem.  Res. 
32:1129–1141. doi:10.1007/s11064-007-9279-z
Topilko, P., S. Schneider-Maunoury, G. Levi, A. Baron-Van Evercooren, A.B. 
Chennoufi, T. Seitanidou, C. Babinet, and P. Charnay. 1994. Krox-20 
controls myelination in the peripheral nervous system. Nature. 371:796–
799. doi:10.1038/371796a0
Wegner, M. 1999. From head to toes: the multiple facets of Sox proteins. Nucleic 
Acids Res. 27:1409–1420. doi:10.1093/nar/27.6.1409
ortholog Sox100B provides evidence for co-option of SoxE proteins into 
vertebrate-specific gene-regulatory networks through altered expression. 
Dev. Biol. 341:267–281. doi:10.1016/j.ydbio.2010.01.038
Estable-Puig, J.F., W.C. Bauer, and J.M. Blumberg. 1965. Technical note: para-
phenylendiamine  staining  of  osmium-fixed  plastic  embedded  tissue  for 
light  and  phase  microscopy.  J.  Neuropathol.  Exp.  Neurol.  24:531–536. 
doi:10.1097/00005072-196507000-00012
Feltri, M.L., D. Graus Porta, S.C. Previtali, A. Nodari, B. Migliavacca, A. Cassetti, 
A. Littlewood-Evans, L.F. Reichardt, A. Messing, A. Quattrini, et al. 2002. 
Conditional disruption of beta 1 integrin in Schwann cells impedes inter-
actions with axons. J. Cell Biol. 156:199–209. doi:10.1083/jcb.200109021
Forster, C., and H.O. Handwerker. 1990. Automatic classification and analysis 
of microneurographic spike data using a PC/AT. J. Neurosci. Methods. 
31:109–118. doi:10.1016/0165-0270(90)90155-9
Friedrich, R.P., B. Schlierf, E.R. Tamm, M.R. Bösl, and M. Wegner. 2005. The class 
III POU domain protein Brn-1 can fully replace the related Oct-6 during 
schwann cell development and myelination. Mol. Cell. Biol. 25:1821–1829. 
doi:10.1128/MCB.25.5.1821-1829.2005
Ghislain, J., and P. Charnay. 2006. Control of myelination in Schwann cells: a 
Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. 
EMBO Rep. 7:52–58. doi:10.1038/sj.embor.7400573
Herbarth, B., V. Pingault, N. Bondurand, K. Kuhlbrodt, I. Hermans-Borgmeyer, 
A. Puliti, N. Lemort, M. Goossens, and M. Wegner. 1998. Mutation of 
the Sry-related Sox10 gene in Dominant megacolon, a mouse model for 
human Hirschsprung disease. Proc. Natl. Acad. Sci. USA. 95:5161–5165. 
doi:10.1073/pnas.95.9.5161
Inoue, K., M. Khajavi, T. Ohyama, S.-i. Hirabayashi, J. Wilson, J.D. Reggin,   
P. Mancias, I.J. Butler, M.F. Wilkinson, M. Wegner, and J.R. Lupski. 2004. 
Molecular mechanism for distinct neurological phenotypes conveyed by   
allelic truncating mutations. Nat. Genet. 36:361–369. doi:10.1038/ng1322
Jaegle, M., W. Mandemakers, L. Broos, R. Zwart, A. Karis, P. Visser, F. Grosveld, 
and D. Meijer. 1996. The POU factor Oct-6 and Schwann cell differentia-
tion. Science. 273:507–510. doi:10.1126/science.273.5274.507
Jaegle, M., M. Ghazvini, W. Mandemakers, M. Piirsoo, S. Driegen, F. Levavasseur, 
S. Raghoenath, F. Grosveld, and D. Meijer. 2003. The POU proteins Brn-2 
and Oct-6 share important functions in Schwann cell development. Genes 
Dev. 17:1380–1391. doi:10.1101/gad.258203
Jessen, K.R., and R. Mirsky. 2005. The origin and development of glial cells in 
peripheral nerves. Nat. Rev. Neurosci. 6:671–682. doi:10.1038/nrn1746
Joseph, N.M., Y.S. Mukouyama, J.T. Mosher, M. Jaegle, S.A. Crone, E.L. Dormand, 
K.F. Lee, D. Meijer, D.J. Anderson, and S.J. Morrison. 2004. Neural crest 
stem cells undergo multilineage differentiation in developing peripheral 
nerves to generate endoneurial fibroblasts in addition to Schwann cells. 
Development. 131:5599–5612. doi:10.1242/dev.01429
Kao, S.C., H. Wu, J. Xie, C.P. Chang, J.A. Ranish, I.A. Graef, and G.R. Crabtree. 2009. 
Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann 
cell differentiation. Science. 323:651–654. doi:10.1126/science.1166562
Kapur, R.P. 1999. Early death of neural crest cells is responsible for total enteric 
aganglionosis in Sox10(Dom)/Sox10(Dom) mouse embryos. Pediatr. Dev. 
Pathol. 2:559–569. doi:10.1007/s100249900162
Kellerer, S., S. Schreiner, C.C. Stolt, S. Scholz, M.R. Bösl, and M. Wegner. 2006. 
Replacement of the Sox10 transcription factor by Sox8 reveals incom-
plete functional equivalence. Development. 133:2875–2886. doi:10.1242/ 
dev.02477
Kim, J., L. Lo, E. Dormand, and D.J. Anderson. 2003. SOX10 maintains multi-
potency and inhibits neuronal differentiation of neural crest stem cells. 
Neuron. 38:17–31. doi:10.1016/S0896-6273(03)00163-6
Kuhlbrodt, K., B. Herbarth, E. Sock, I. Hermans-Borgmeyer, and M. Wegner. 
1998. Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 
18:237–250.
Le, N., R. Nagarajan, J.Y. Wang, T. Araki, R.E. Schmidt, and J. Milbrandt. 2005. 
Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies 
Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. 
Natl. Acad. Sci. USA. 102:2596–2601. doi:10.1073/pnas.0407836102
LeBlanc, S.E., R.M. Ward, and J. Svaren. 2007. Neuropathy-associated Egr2 
mutants disrupt cooperative activation of myelin protein zero by Egr2 and 
Sox10. Mol. Cell. Biol. 27:3521–3529. doi:10.1128/MCB.01689-06
Ludwig, A., B. Schlierf, A. Schardt, K.A. Nave, and M. Wegner. 2004. Sox10-rtTA 
mouse line for tetracycline-inducible expression of transgenes in neural 
crest cells and oligodendrocytes. Genesis. 40:171–175. doi:10.1002/gene 
.20083
Maka, M., C.C. Stolt, and M. Wegner. 2005. Identification of Sox8 as a modi-
fier gene in a mouse model of Hirschsprung disease reveals underlying   
molecular  defect.  Dev.  Biol.  277:155–169.  doi:10.1016/j.ydbio.2004 
.09.014
Martini, R. 1997. Animal models for inherited peripheral neuropathies. J. Anat. 
191:321–336. doi:10.1046/j.1469-7580.1997.19130321.x